Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Diet
Not applicable · Testing MyIBDDiet app · 1 site · University of Alberta
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing MyIBDDiet app. Condition(s) listed: Inflammatory Bowel Disease (IBD).
Participants are assigned to groups by chance (randomized).
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 18 and older
- Any sex
Some of the main requirements, copied from the record:
- ≥18 years
- Able to provide informed consent
- Established diagnosis of IBD determined by treating physician
Plus 3 more requirement(s). There are also 10 reasons someone might not be able to join (exclusion criteria). Only the trial team can confirm whether you qualify.
What's involved
- About 40 participants are expected to take part.
- Start date: 2026-03-15.
- Main results expected around 2028-12-01 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Canada.
Main thing being measured
- Usability of MyIBDDiet App (Through study completion - 60 days)
In the researchers’ words
The goal of this clinical trial is to learn if an app designed for diet education can help patients with inflammatory bowel disease (IBD) learn about healthy eating. The main question\[s\] it aims to answer are: * Is the app easy to use? * Is the app useful?
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Inflammatory Bowel Disease (IBD) |
| Lead sponsor | University of Alberta |
| Enrollment | 40 (estimated) |
| Start date | 2026-03-15 |
| Primary completion (est.) | 2028-12-01 |
| First posted | 2024-11-12 |
| Last updated | 2026-05-07 |
| Official title | A Pilot Randomized Trial Investigating the MyIBDDiet App to Improve Self-management of an Anti-inflammatory Diet for Individuals With Inflammatory Bowel Disease |
| ClinicalTrials.gov ID | NCT06683105 |
Interventions
- MyIBDDiet app (Other)
Participants in the Control crossover arm will be administered the intervention (using the app) for 30 days, and participants in the MYIBDDiet arm will use the app for 60 days.
Full eligibility criteria (from the record)
Inclusion Criteria: 1. ≥18 years 2. Able to provide informed consent 3. Established diagnosis of IBD determined by treating physician 4. Not in acute flare 5. Not pregnant 6. Willing and able to comply with all required study procedures Exclusion Criteria: 1. Short bowel syndrome 2. High ostomy output 3. Intestinal strictures 4. Pregnancy or breastfeeding 5. Malnutrition (evaluated by Canadian Nutrition Screening Tool (CNST) ) 6. Conditions requiring dietary restrictions (e.g. Celiac disease, kidney disease, diabetes, eosinophilic esophagitis) 7. Have other conditions that may require low fibre diet such as irritable bowel syndrome, gastroparesis. 8. Currently on a therapeutic diet 9. Already on a diet for IBD or using diet tool for IBD (e.g. Mediterranean or anti-inflammatory diet) 10. Active malignancy
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| Zeidler Ledcor Centre, University of Alberta | Edmonton, Alberta | Canada | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.